Galmed Pharmaceuticals Ltd. (GLMD)
4.02
-0.28
(-6.62%)
USD |
NASDAQ |
Aug 24, 16:00
4.02
0.00 (0.00%)
After-Hours: 20:00
Galmed Pharmaceuticals Total Assets (Quarterly) : 16.03M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 16.03M |
| December 31, 2025 | 18.63M |
| September 30, 2025 | 21.58M |
| June 30, 2025 | 22.94M |
| March 31, 2025 | 18.68M |
| December 31, 2024 | 18.50M |
| September 30, 2024 | 20.95M |
| June 30, 2024 | 13.34M |
| March 31, 2024 | 14.52M |
| December 31, 2023 | 16.63M |
| September 30, 2023 | 17.64M |
| June 30, 2023 | 13.28M |
| March 31, 2023 | 14.79M |
| December 31, 2022 | 16.56M |
| September 30, 2022 | 20.87M |
| June 30, 2022 | 23.58M |
| March 31, 2022 | 30.20M |
| December 31, 2021 | 36.60M |
| September 30, 2021 | 44.30M |
| June 30, 2021 | 52.32M |
| March 31, 2021 | 60.38M |
| December 31, 2020 | 52.38M |
| September 30, 2020 | 59.95M |
| June 30, 2020 | 64.85M |
| March 31, 2020 | 70.44M |
| Date | Value |
|---|---|
| December 31, 2019 | 77.14M |
| September 30, 2019 | 81.35M |
| June 30, 2019 | 85.11M |
| March 31, 2019 | 87.84M |
| December 31, 2018 | 90.60M |
| September 30, 2018 | 92.89M |
| June 30, 2018 | 94.85M |
| March 31, 2018 | 16.30M |
| December 31, 2017 | 19.64M |
| September 30, 2017 | 9.677M |
| June 30, 2017 | 10.03M |
| March 31, 2017 | 12.65M |
| December 31, 2016 | 16.45M |
| September 30, 2016 | 19.46M |
| June 30, 2016 | 18.00M |
| March 31, 2016 | 21.08M |
| December 31, 2015 | 24.26M |
| September 30, 2015 | 26.57M |
| June 30, 2015 | 29.11M |
| March 31, 2015 | 31.05M |
| December 31, 2014 | 32.92M |
| September 30, 2014 | 36.18M |
| June 30, 2014 | 37.48M |
| March 31, 2014 | 39.88M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| BioLineRx Ltd. | 38.80M |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 383.16M |
| Can-Fite BioPharma Ltd. | -- |
| Revium Recovery, Inc. | 18.79M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.079M |
| Shareholders Equity (Quarterly) | 13.95M |
| Current Ratio | 7.709 |